Hybridization of Fluoro-amodiaquine (FAQ) with Pyrimidines: Synthesis and Antimalarial Efficacy of FAQ–Pyrimidines | ACS Medicinal Chemistry Letters
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy | Science
4 Mefloquine | Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis |The National Academies Press
β-Carboline Derivatives Tackling Malaria: Biological Evaluation and Docking Analysis | ACS Omega
Introducing the Concept of a New Pre-Referral Treatment for Severely Ill Febrile Children at Community Level : A Sociological Approach in Guinea-Bissau
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial - The Lancet Infectious Diseases
Comparison of the Primary Outcome, by the Peto Odds Ratio (OR) Method | Download Table
Parasitologia | Free Full-Text | Antimalarial Drug Strategies to Target Plasmodium Gametocytes
Molecules | Free Full-Text | Bioactivities and Mode of Actions of Dibutyl Phthalates and Nocardamine from Streptomyces sp. H11809
Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect
Antimalarial resistance markers in Plasmodium falciparum isolates, by... | Download Scientific Diagram
Antimalarial chemoprophylaxis for forest goers could help accelerate malaria elimination in Cambodia — Centre for Tropical Medicine and Global Health
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study - The Lancet Infectious Diseases
Antimalarial application of quinones: A recent update - ScienceDirect
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial - The Lancet Infectious Diseases
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial - The Lancet
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance | Science Translational Medicine
The disposition of amodiaquine in Zambians and Nigerians with malaria. - Abstract - Europe PMC
